Imaging of Musculoskeletal Bacterial Infections by [124I]FIAU-PET/CT

Background Traditional imaging techniques for the localization and monitoring of bacterial infections, although reasonably sensitive, suffer from a lack of specificity. This is particularly true for musculoskeletal infections. Bacteria possess a thymidine kinase (TK) whose substrate specificity is distinct from that of the major human TK. The substrate specificity difference has been exploited to develop a new imaging technique that can detect the presence of viable bacteria. Methodology/Principal Findings Eight subjects with suspected musculoskeletal infections and one healthy control were studied by a combination of [124I]FIAU-positron emission tomography and CT ([124I]FIAU-PET/CT). All patients with proven musculoskeletal infections demonstrated positive [124I]FIAU-PET/CT signals in the sites of concern at two hours after radiopharmaceutical administration. No adverse reactions with FIAU were observed. Conclusions/Significance [124I]FIAU-PET/CT is a promising new method for imaging bacterial infections.

[1]  O. Muzik,et al.  Biodistribution, PET, and Radiation Dosimetry Estimates of HSV-tk Gene Expression Imaging Agent 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)-5-Iodouracil in Normal Dogs , 2007, Journal of Nuclear Medicine.

[2]  M. Pomper,et al.  Virus-Associated Tumor Imaging by Induction of Viral Gene Expression , 2007, Clinical Cancer Research.

[3]  R. Barrack,et al.  Periprosthetic infection: what are the diagnostic challenges? , 2006, The Journal of bone and joint surgery. American volume.

[4]  Alberto Signore,et al.  Nuclear medicine imaging of diabetic foot infection: results of meta-analysis , 2006, Nuclear medicine communications.

[5]  J. Martín-Comín,et al.  Labeling of antibiotics for infection diagnosis. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[6]  K. Strobel,et al.  18F FDG-PET imaging in musculoskeletal infection. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[7]  J. Buscombe The future of infection imaging. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[8]  J. Hodler,et al.  The value of FDG-PET in patients with painful total knee arthroplasty , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  J. Parvizi,et al.  Diagnosis of periprosthetic infection. , 2006, The Journal of bone and joint surgery. American volume.

[10]  B. Masri,et al.  The management of peri-prosthetic infection in total joint arthroplasty. , 2006, The Journal of bone and joint surgery. British volume.

[11]  B. Peters,et al.  Pharmacologic and toxicologic evaluation of C. novyi-NT spores. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  M. Imran,et al.  Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  K. Kinzler,et al.  Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Nichols,et al.  Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Bert Vogelstein,et al.  Bacteriolytic therapy can generate a potent immune response against experimental tumors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Love,et al.  Radionuclide imaging of infection. , 2004, Journal of nuclear medicine technology.

[17]  K. Van Laere,et al.  99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine , 2004, Nuclear medicine communications.

[18]  H. Demos,et al.  Detection of musculoskeletal infection with 18F-FDG PET: review of the current literature. , 2004, Journal of nuclear medicine technology.

[19]  K. Laere,et al.  99mTc-Ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  M. Hämäläinen,et al.  Specificity of 99mTc-ciprofloxacin imaging. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  D. Le Guludec,et al.  Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  T. Appelboom,et al.  Infecton is not specific for bacterial osteo-articular infective pathology , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  J. Meller,et al.  The role of nuclear medicine in infection and inflammation. , 2001, The Lancet. Infectious diseases.

[24]  K. Kinzler,et al.  Combination bacteriolytic therapy for the treatment of experimental tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Lercher,et al.  Quantitative kinetics of [124I]FIAU in cat and man. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  M. Hämäläinen,et al.  Extended combined 99mTc-white blood cell and bone imaging improves the diagnostic accuracy in the detection of hip replacement infections , 2001, European Journal of Nuclear Medicine.

[27]  A. Karlsson,et al.  Cloning of the cDNA and Chromosome Localization of the Gene for Human Thymidine Kinase 2* , 1997, The Journal of Biological Chemistry.

[28]  S. Eriksson,et al.  Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity , 1996, Antimicrobial agents and chemotherapy.

[29]  J. Bomanji,et al.  Comparison of 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection , 1996, The Lancet.

[30]  N. Pallua,et al.  Technetium—99M human immunoglobulin (HIG): A new substance for scintigraphic detection of bone and joint infections , 1996, Microsurgery.

[31]  H. Conjeevaram,et al.  Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.

[32]  S. Goldsmith,et al.  Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  B. Isaksson,et al.  Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. , 1980, Scandinavian journal of clinical and laboratory investigation.